ArticleTherapeutics and clinical risk management2015

Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia.

Wissam K Kabbara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.